NFE2L2 and asthma: This study aimed to elucidate the molecular mechanisms underlying non-type 2 airway inflammation, with a specific focus on impaired antioxidant defense, and to identify potential mediators that can be used as therapeutic targets using an Nrf2−/− asthma mouse model.